Factors associated with low adherence to medication among patients with type 2 diabetes at different healthcare facilities in southern Bangladesh

References

• Islam SMS, Purnat TD, Phuong NTA, et al. Non‐Communicable Diseases (NCDs) in developing countries: a symposium report. Global Health. 2014;10:81.
   Web of Science ®Google Scholar
• Federation ID, Atlas I. International Diabetes Federation. IDF diabetes atlas. 6th ed. Brussels, Belgium: International Diabetes Federation; 2013.
   Google Scholar
• Whiting DR, Guariguata L, Weil C, et al. IDF diabetes atlas: global estimates of the prevalence of diabetes for 2011 and 2030. Diabetes Res Clin Pract. 2011;94:311–7.
   PubMed Web of Science ®Google Scholar
• Akter S, Rahman MM, Abe SK, et al. Prevalence of diabetes and prediabetes and their risk factors among Bangladeshi adults: a nationwide survey. Bull World Health Organ. 2014;92:204–213A.
   PubMed Web of Science ®Google Scholar
• Afroz A, Alam K, Ali L, et al. Type 2 diabetes mellitus in Bangladesh: a prevalence based cost-of-illness study. BMC Health Serv Res. 2019;19:601.
   PubMed Web of Science ®Google Scholar
• Rawal LB, Kanda K, Biswas T, et al. Non-communicable disease (NCD) corners in public sector health facilities in Bangladesh: a qualitative study assessing challenges and opportunities for improving NCD services at the primary healthcare level. BMJ Open. 2019;9:e029562.
   PubMed Web of Science ®Google Scholar
• Zimmet P, Alberti K, Shaw J. Global and societal implications of the diabetes epidemic. Nature. 2001;414:782–787.
   PubMed Web of Science ®Google Scholar
• Fowler MJ. Microvascular and macrovascular complications of diabetes. Clin Diabetes. 2008;26:77–82.
   Google Scholar
• Islam SMS, Alam DS, Wahiduzzaman M, et al. Clinical characteristics and complications of patients with type 2 diabetes attending an urban hospital in Bangladesh. Diabetes Metab Syndr. 2015;9:7–13.
   Web of Science ®Google Scholar
• Melikian C, White TJ, Vanderplas A, et al. Adherence to oral antidiabetic therapy in a managed care organization: a comparison of monotherapy, combination therapy, and fixed-dose combination therapy. Clin Ther. 2002;24:460–467.
   PubMed Web of Science ®Google Scholar
• Meichenbaum D, Turk DC. Facilitating treatment adherence: A practitioner’s guidebook. Plenum Press; Washington, USA; 1987.
   Google Scholar
• Brown MT, Bussell JK, editors. Medication adherence: WHO cares? Mayo clinic proceedings. 2011;86:304–314 4 doi:https://doi.org/10.4065/mcp.2010.0575
   PubMed Web of Science ®Google Scholar
• Swaby P, Wilson E, Swaby S, et al. Chronic diseases management in the Jamaican setting: HOPE worldwide Jamaica’s experience. P N G Med J. 2001;44:171–175.
   Google Scholar
• Durán-Varela BR, Rivera-Chavira B, Franco-Gallegos E. Pharmacological therapy compliance in diabetes. Salud Públ Méx. 2001;43:233–236.
   Web of Science ®Google Scholar
• Raum E, Krämer HU, Rüter G, et al. Medication non-adherence and poor glycaemic control in patients with type 2 diabetes mellitus. Diabetes Res Clin Pract. 2012;97:377–384.
   PubMed Web of Science ®Google Scholar
• Feldman BS, Cohen-Stavi CJ, Leibowitz M, et al. Defining the role of medication adherence in poor glycemic control among a general adult population with diabetes. PLoS One. 2014;9:e108145.
   PubMed Web of Science ®Google Scholar
• Polonsky WH, Henry RR. Poor medication adherence in type 2 diabetes: recognizing the scope of the problem and its key contributors. Patient Prefer Adherence. 2016;10:1299.
   PubMed Web of Science ®Google Scholar
• Association AD. Standards of medical care in diabetes—2017 abridged for primary care providers. Clin Diabetes. 2017;35:5.
   PubMedGoogle Scholar
• Mirahmadizadeh A, Khorshidsavar H, Seif M, et al. Adherence to medication, diet and physical activity and the associated factors amongst patients with type 2 diabetes. Diabetes Therapy. 2020;11:479–494.
   Web of Science ®Google Scholar
• Aminde LN, Tindong M, Ngwasiri CA, et al. BMC endocrine disorders. Adherence to antidiabetic medication and factors associated with non-adherence among patients with type-2 diabetes mellitus in two regional hospitals in Cameroon. 2019;19:35.
   Google Scholar
• Morisky DE, Ang A, Krousel‐Wood M, et al. Predictive validity of a medication adherence measure in an outpatient setting. J Clin Hypertens. 2008;10:348–354.
   PubMed Web of Science ®Google Scholar
• Sayers SL, Riegel B, Pawlowski S, et al. Social support and self-care of patients with heart failure. Ann Behav Med. 2008;35:70–79.
   PubMed Web of Science ®Google Scholar
• Fialko L, Garety PA, Kuipers E, et al. A large-scale validation study of the Medication Adherence Rating Scale (MARS). Schizophr Res. 2008;100:53–59.
   PubMed Web of Science ®Google Scholar
• Saleh F, Mumu SJ, Ara F, et al. Non-adherence to self-care practices & medication and health related quality of life among patients with type 2 diabetes: a cross-sectional study. BMC Public Health. 2014;14:431.
   Web of Science ®Google Scholar
• Arulmozhi S, Mahalakshmy T. Self care and medication adherence among type 2 diabetics in Puducherry, Southern India: a hospital based study. J Clin Diagn Res. 2014;8:UC01.
   PubMedGoogle Scholar
• Kalyango JN, Owino E, Nambuya AP. Non-adherence to diabetes treatment at Mulago Hospital in Uganda: prevalence and associated factors. Afr Health Sci. 2008;8:67–73.
   PubMed Web of Science ®Google Scholar
• Ho PM, Bryson CL, Rumsfeld JS. Medication adherence: its importance in cardiovascular outcomes. Circulation. 2009;119:3028–3035.
   PubMed Web of Science ®Google Scholar
• Garber MC, Nau DP, Erickson SR, et al. The concordance of self-report with other measures of medication adherence: a summary of the literature. Med Care. 2004;42:649–652.
   PubMed Web of Science ®Google Scholar
• Jin J, Sklar GE, Oh VMS, et al. Factors affecting therapeutic compliance: A review from the patient’s perspective. Ther Clin Risk Manag. 2008;4:269.
   PubMedGoogle Scholar
• Wabe NT, Angamo MT, Hussein S. Medication adherence in diabetes mellitus and self management practices among type-2 diabetics in Ethiopia. N Am J Med Sci. 2011;3:418.
   Google Scholar
• Seligman HK, Jacobs EA, López A, et al. Food insecurity and glycemic control among low-income patients with type 2 diabetes. Diabetes Care. 2012;35:233–238.
   PubMed Web of Science ®Google Scholar
• Abebe SM, Berhane Y, Worku A. Barriers to diabetes medication adherence in North West Ethiopia. Springerplus. 2014;3:195.
   PubMedGoogle Scholar
• Sokol MC, McGuigan KA, Verbrugge RR, et al. Impact of medication adherence on hospitalization risk and healthcare cost. Med Care. 2005;43:521–530.
   PubMed Web of Science ®Google Scholar
• Meyer D, Leventhal H, Gutmann M. Common-sense models of illness: the example of hypertension. Health Psychol. 1985;4:115.
   PubMed Web of Science ®Google Scholar
• Osterberg L, Blaschke T. Adherence to medication. N Engl J Med. 2005;353:487–497.
   PubMed Web of Science ®Google Scholar
• DiMatteo MR. Variations in patients’ adherence to medical recommendations: a quantitative review of 50 years of research. Med Care. 2004;42:200–209.
   PubMed Web of Science ®Google Scholar
• Kindmalm L, Melander A, Nilsson JLG. Refill adherence of antihyperglycaemic drugs related to glucose control (HbA 1c) in patients with type 2 diabetes. Acta Diabetol. 2007;44:209–213.
   PubMed Web of Science ®Google Scholar
• Kerr EA, Zikmund-Fisher BJ, Klamerus ML, et al. The role of clinical uncertainty in treatment decisions for diabetic patients with uncontrolled blood pressure. Ann Intern Med. 2008;148:717–727.
   Web of Science ®Google Scholar
• Riaz M, Basit A, Fawwad A, et al. Factors associated with non-adherence to insulin in patients with type 1 diabetes. Pak J Med Sci. 2014;30:233.
   PubMed Web of Science ®Google Scholar
• Mayberry LS, Osborn CY. Family support, medication adherence, and glycemic control among adults with type 2 diabetes. Diabetes Care. 2012;35:1239–1245.
   PubMed Web of Science ®Google Scholar